AVENUE THERAPEUTICS, INC. - Common Stock, $0.0001 Par Value (ATXI)

Historical Holders from Q2 2024 to Q1 2025

Symbol
ATXI on OTC
CUSIP
05360L403
Type / Class
Equity / Common Stock, $0.0001 Par Value
Shares outstanding
3.19M
All holders as of March 31, 2025
Q1 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-7
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AVENUE THERAPEUTICS, INC. - Common Stock, $0.0001 Par Value (ATXI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Fortress Biotech, Inc. 10.3% -25% $108K $11.1K 329K +11.4% Fortress Biotech, Inc. Mar 31, 2025
Ikarian Capital, LLC 6.8% $46.2K 140K Ikarian Capital, LLC Dec 31, 2024
ARMISTICE CAPITAL, LLC 4.99% $33.1K 100K Armistice Capital, LLC Dec 31, 2024

Institutional Holders of AVENUE THERAPEUTICS, INC. - Common Stock, $0.0001 Par Value (ATXI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 0 $0 -$385K 0
2024 Q4 193K $385K -$102K $2.00 7
2024 Q3 198K $492K +$202K $2.49 8
2024 Q2 116K $407K +$407K $3.50 8